Erythrocin Tablet 250mg Indications
Erythrocin 250mg is primarily indicated in conditions like Acne vulgaris, Alternative to penicillin in hypersensitive patients, Bacterial infections, Bone and joint infection, Breast cancer, Bronchitis, Endocarditis, Erythrasma, Eye infections, Gl infections, Gonorrhoea, Heart failure, Lower respiratory tract infections, Lymphogranuloma venereum, Ophthalmia neonatorum, Otitis media, Pharyngitis, Pneumonia, Prophylaxis of bacterial endocarditis, Rosacea, Sexually transmitted infections, Sinusitis, Skin infections, Soft tissue infections, Supraventricular arrhythmias (particularly atrial fibrillation), Surgical prophylaxis, Syphilis, Upper respiratory tract infections, and can also be given in adjunctive therapy as an alternative drug of choice in Diphtheria, Early lyme disease.
The severe or irreversible adverse effects of Erythrocin 250mg, which give rise to further complications include Tinnitus, Pseudomembranous colitis, Urticaria, Hepatitis, Pancreatitis, Stevens johnson syndrome, Jaundice, Jaundice, Stevens johnson syndrome, Eosinophilia, Thrombophlebitis, Eosinophilia, Interstitial nephritis, Psychosis, Porphyria., Erythrocin 250mg produces potentially life-threatening effects which include Hepatotoxicity, QT prolongation, Severe skin reactions, Torsades de pointes. which are responsible for the discontinuation of Erythrocin 250mg therapy.,The signs and symptoms that are produced after the acute overdosage of Erythrocin 250mg include Nausea, Severe vomiting, Diarrhea, Torsades de pointes, Hearing loss., The symptomatic adverse reactions produced by Erythrocin 250mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Anorexia, Fever, Skin reactions, Abdominal pain, Sweating, Maculopapular rash, Rashes, Pruritus, Gl symptoms, Cramps, Elevation of liver enzymes, Hypersensitivity, Cholestasis, Reaction at injection site, dizziness.
Calcium is contraindicated in conditions like Hypercalcaemia, Hypercalciuria, Renal calculi.
Erythrocin 250mg should be used with caution in patients with impaired renal function, pre-existing arrhythmias, dehydration, diarrhoea, malabsorption or diseases associated with elevated vitamin D concentrations such as sarcoidosis. Solution of calcium salts are irritant and care should be taken to prevent extravasation during intravenous injection. Generally calcium salts should be avoided in patients with calcium renal calculi. Plasma-calcium concentrations should be monitored closely in patients with renal insufficiency and during parentral administration and if large doses of vitamin D are used.